Navigation Links
Upsher-Smith Launches B-Nexa® Prescription Prenatal Vitamin With B Vitamins and Ginger for Nausea and Vomiting of Pregnancy
Date:1/23/2012

MAPLE GROVE, Minn., Jan. 23, 2012 /PRNewswire/ -- Pregnant women who suffer from nausea and vomiting of pregnancy (NVP) now have a new option: B-Nexa®, a prescription prenatal vitamin launched today by Upsher-Smith Laboratories, Inc.  B-Nexa® is designed specifically with B vitamins and ginger to help calm NVP, also known as morning sickness, the most common symptom of pregnancy.(1,2)  "Morning sickness" is not the best term to accurately describe symptoms of NVP because the condition affects 83% of pregnant women throughout the day.(2,3) 

(Photo:  http://photos.prnewswire.com/prnh/20120123/NY39344 )

"B-Nexa® is a new option in the prenatal nutrition market that has been designed to help calm nausea and vomiting of pregnancy, with vitamin B6 and ginger, while also providing women with essential folic acid," said Wesley Mark Todd, MD, Senior Director Medical Affairs, Upsher-Smith Laboratories, Inc. "With the launch of B-Nexa®, Upsher-Smith is pleased to have another opportunity to demonstrate our commitment to women's prenatal health."

Taken once or twice daily, B-Nexa® contains vitamin B6 and ginger to help calm nausea and vomiting during pregnancy.  Each antihistamine-free tablet also contains 1.2 mg folic acid for expectant moms and developing babies.(1)  The American College of Obstetricians and Gynecologists (ACOG) recommends vitamin B6 as a first-line approach for morning sickness, and also suggests ginger as a non-drug option.(4)  

For more information about B-Nexa®, visit http://www.b-nexa.com.

About NVP
Although commonly known as morning sickness, NVP can occur at any time throughout the day and affects 70 to 85% of pregnant women.  Approximately 50% of pregnant women experience both nausea and vomiting, while 25% experience only nausea. Studies have shown that women taking a multivitamin regularly at the time of conception were less likely to have severe cases of NVP.(4)   In most cases, the condition affects women only during the first and early second trimesters, although up to 15% of women continue to have symptoms throughout pregnancy.(3) 

NVP can cause significant distress in many women and can lead to feelings of anxiety about how the fetus may be affected.  Some women do not seek treatment for morning sickness because of concerns about drug therapy during pregnancy or because they don't know treatments are available.  Even a less severe case of NVP can detract from the joy of pregnancy and can affect a woman's general well being.(5)

Important Safety Information
You should not take more than 1 mg per day of folic acid unless you are under the care of a healthcare professional, as it may mask the symptoms of a potentially more serious condition.

Taking ginger if you have a bleeding disorder or while you are also taking a blood thinner or other medication that affects the blood may increase the risk of bleeding.

Please see the full Prescribing Information for a complete list of warnings and precautions. 
http://b-nexa.com/prescribing-information

About the Nexa® Family of Products
Upsher-Smith Laboratories, Inc. is committed to providing nutritional support to mothers before, during and after pregnancy.  Designed to provide ingredients to help support a healthy pregnancy, the Nexa® family of products includes Nexa® Select Capsules (Rx prenatal vitamin with 325 mg of plant-based DHA, more than any other single gel capsule prescription prenatal vitamin taken once a day),(6-10) PreNexa® Capsules (Rx prenatal vitamin with plant-based DHA) that offers essential nutrition for mom and baby including 1.25 mg folic acid, and B-Nexa® Tablets (Rx prenatal vitamin formulated with B-vitamins and ginger) to help calm nausea and vomiting of pregnancy. To find out more about the Nexa® family of products or to obtain complete prescribing information, visit http://www.nexavitamins.com.

About Upsher-Smith
Upsher-Smith Laboratories, Inc. is a rapidly growing pharmaceutical company that manufactures, distributes, and markets both prescription and consumer products.  Privately held since 1919, the company strives to recognize the unmet healthcare needs of its customers.  Upsher-Smith prides itself on providing safe, effective, and economical therapies to the ever-changing healthcare environment.  For additional information, visit http://www.upsher-smith.com.   

References

(1)  Upsher-Smith Laboratories, Inc., B-Nexa® Prescribing Information.

(2)  Jewell D, Young G. Interventions for Nausea and Vomiting in Early Pregnancy.  Cochrane Database Syst Rev 2003;(4):CD000145.

(3)  Badell M, Ramin S, Smith J. Treatment Options for Nausea and Vomiting During Pregnancy. Pharmacotherapy. 2006;26(9):1273-1287. Accessed on 10/12/11 at www.medscape.com/viewarticle/545629.

(4)  American College of Obstetricians and Gynecologists. ACOG practice bulletin: Nausea and Vomiting of Pregnancy. Obstet Gynecol 2004;103:803–814.

(5)  Einarson A, et al. Treatment of Nausea and Vomiting in Pregnancy.  Motherisk Update. Canadian Family Physician. December 2007;53:2109-2111.

(6)  Nexa Select. [package insert]. Minneapolis, MN: Upsher-Smith Laboratories, Inc; 2010.

(7)  CitraNatal Harmony [package insert]. San Antonio, TX: Mission Pharmacal Company; 2010.

(8)  Natelle One [package insert]. Philadelphia, PA: Azur Pharma, Inc; 2009.

(9)  NeevoDHA [package insert]. Covington, LA: PamLab, LLC; 2011.

(10)  Prefera OB ONE [package insert]. Marietta, GA: Alaven Pharmaceutical LLC; 2011.

 

 


'/>"/>
SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
2. iHealth Lab Launches Personalized Web Portal to Store Your Vitals
3. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
4. Neogen Launches Fully Quantitative Lateral Flow Test for DON
5. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
6. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
7. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
8. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
9. Life Technologies Launches 3500 Dx Series Genetic Analyzers for In Vitro Diagnostic Use in China
10. Reaction Biology Launches Recombinant Methyltransferase Line
11. joimax® Launches Numerous Innovations at EuroSpine Milan From 19 To 21 October 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking ... Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity as ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology:
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/23/2016)... 2016 Einzigartige ... und Stimmerkennung mit Passwörtern     ... MESG ), ein führender Anbieter digitaler Kommunikationsdienste, ... SpeechPro zusammenarbeitet, um erstmals dessen Biometrietechnologie einzusetzen. ... Möglichkeit angeboten, im Rahmen mobiler Apps neben ...
Breaking Biology News(10 mins):